210 related articles for article (PubMed ID: 32629122)
1. Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis.
Singal AG; Tiro JA; Murphy CC; Blackwell JM; Kramer JR; Khan A; Liu Y; Zhang S; Phillips JL; Hernaez R
Clin Gastroenterol Hepatol; 2021 May; 19(5):987-995.e1. PubMed ID: 32629122
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis.
Farvardin S; Patel J; Khambaty M; Yerokun OA; Mok H; Tiro JA; Yopp AC; Parikh ND; Marrero JA; Singal AG
Hepatology; 2017 Mar; 65(3):875-884. PubMed ID: 27531684
[TBL] [Abstract][Full Text] [Related]
3. Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort.
Parikh ND; Tayob N; Al-Jarrah T; Kramer J; Melcher J; Smith D; Marquardt P; Liu PH; Tang R; Kanwal F; Singal AG
JAMA Netw Open; 2022 Jul; 5(7):e2223504. PubMed ID: 35867057
[TBL] [Abstract][Full Text] [Related]
4. Clinician-Level Knowledge and Barriers to Hepatocellular Carcinoma Surveillance.
Wong RJ; Jones PD; Niu B; Therapondos G; Thamer M; Kshirsagar O; Zhang Y; Pinheiro P; Kyalwazi B; Fass R; Khalili M; Singal AG
JAMA Netw Open; 2024 May; 7(5):e2411076. PubMed ID: 38743424
[TBL] [Abstract][Full Text] [Related]
5. Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis.
Dalton-Fitzgerald E; Tiro J; Kandunoori P; Halm EA; Yopp A; Singal AG
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):791-8.e1. PubMed ID: 25019694
[TBL] [Abstract][Full Text] [Related]
6. Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance.
Singal AG; Reddy S; Radadiya Aka Patel H; Villarreal D; Khan A; Liu Y; Cerda V; Rich NE; Murphy CC; Tiro JA; Kramer JR; Hernaez R
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2818-2825.e1. PubMed ID: 34902568
[TBL] [Abstract][Full Text] [Related]
7. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
Singal AG; Zhang E; Narasimman M; Rich NE; Waljee AK; Hoshida Y; Yang JD; Reig M; Cabibbo G; Nahon P; Parikh ND; Marrero JA
J Hepatol; 2022 Jul; 77(1):128-139. PubMed ID: 35139400
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.
Singal AG; Tiro J; Li X; Adams-Huet B; Chubak J
J Clin Gastroenterol; 2017 Aug; 51(7):650-655. PubMed ID: 27870642
[TBL] [Abstract][Full Text] [Related]
9. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.
Kim NJ; Rozenberg-Ben-Dror K; Jacob DA; Rich NE; Singal AG; Aby ES; Yang JD; Nguyen V; Pillai A; Fuchs M; Moon AM; Shroff H; Agarwal PD; Perumalswami P; Chandna S; Zhou K; Patel YA; Latt NL; Wong R; Duarte-Rojo A; Lindenmeyer CC; Frenette C; Ge J; Mehta N; Yao F; Benhammou JN; Bloom PP; Leise M; Kim HS; Levy C; Barnard A; Khalili M; Ioannou GN
Clin Gastroenterol Hepatol; 2022 Jan; 20(1):183-193. PubMed ID: 32927050
[TBL] [Abstract][Full Text] [Related]
10. Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta-Analysis.
Wolf E; Rich NE; Marrero JA; Parikh ND; Singal AG
Hepatology; 2021 Feb; 73(2):713-725. PubMed ID: 32383272
[TBL] [Abstract][Full Text] [Related]
11. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
[TBL] [Abstract][Full Text] [Related]
12. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
Goldberg DS; Taddei TH; Serper M; Mehta R; Dieperink E; Aytaman A; Baytarian M; Fox R; Hunt K; Pedrosa M; Pocha C; Valderrama A; Kaplan DE
Hepatology; 2017 Mar; 65(3):864-874. PubMed ID: 27531119
[TBL] [Abstract][Full Text] [Related]
13. Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance.
Simmons OL; Feng Y; Parikh ND; Singal AG
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):766-773. PubMed ID: 30056183
[TBL] [Abstract][Full Text] [Related]
14. Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis.
Singal AG; Patibandla S; Obi J; Fullington H; Parikh ND; Yopp AC; Marrero JA
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1925-1932.e1. PubMed ID: 32920214
[TBL] [Abstract][Full Text] [Related]
15. Proportion of Time Covered by Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis.
Daher D; Seif El Dahan K; Yekkaluri S; Gopal P; Rich NE; Parikh ND; Murphy CC; Singal AG
Am J Gastroenterol; 2024 May; 119(5):875-882. PubMed ID: 37975606
[TBL] [Abstract][Full Text] [Related]
16. Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial.
Singal AG; Tiro JA; Murphy CC; Marrero JA; McCallister K; Fullington H; Mejias C; Waljee AK; Pechero Bishop W; Santini NO; Halm EA
Hepatology; 2019 Jan; 69(1):121-130. PubMed ID: 30070379
[TBL] [Abstract][Full Text] [Related]
17. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States.
Davila JA; Morgan RO; Richardson PA; Du XL; McGlynn KA; El-Serag HB
Hepatology; 2010 Jul; 52(1):132-41. PubMed ID: 20578139
[TBL] [Abstract][Full Text] [Related]
18. Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
Tavakoli H; Robinson A; Liu B; Bhuket T; Younossi Z; Saab S; Ahmed A; Wong RJ
Dig Dis Sci; 2017 Aug; 62(8):2174-2181. PubMed ID: 28474143
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis.
Choi DT; Kum HC; Park S; Ohsfeldt RL; Shen Y; Parikh ND; Singal AG
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):976-987.e4. PubMed ID: 30616961
[TBL] [Abstract][Full Text] [Related]
20. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
